Lipid responses of hypercholesterolemic men to oat-bran and wheat-bran intake
- PMID: 1654739
- DOI: 10.1093/ajcn/54.4.678
Lipid responses of hypercholesterolemic men to oat-bran and wheat-bran intake
Abstract
The hypocholesterolemic effects of oat bran (OB) have been recently challenged. To carefully document the hypocholesterolemic effects of OB, 20 hypercholesterolemic men admitted to a metabolic ward were randomly allocated to either OB or wheat bran (WB) for 21 d after a 7-d control-diet period. Control and treatment diets were designed to be identical in energy content and nutrients, differing only in the amount of soluble fiber. After 21 d, OB significantly decreased total cholesterol by 12.8% (P less than 0.001), low-density-lipoprotein cholesterol by 12.1% (P less than 0.004), and apolipoprotein B-100 by 13.7% (P less than 0.001) whereas WB had no significant effect. High-density-lipoprotein cholesterol and apolipoprotein A-I did not change significantly in either group. Serum triglycerides decreased by 10% in both groups but the decrease was only significant (P less than 0.04) in WB subjects. OB but not WB significantly reduced total cholesterol and other atherogenic lipoprotein fractions independent of other dietary changes.
Similar articles
-
Hypocholesterolemic effects of oat-bran or bean intake for hypercholesterolemic men.Am J Clin Nutr. 1984 Dec;40(6):1146-55. doi: 10.1093/ajcn/40.6.1146. Am J Clin Nutr. 1984. PMID: 6095635 Clinical Trial.
-
A controlled study on the effect of beta-glucan-rich oat bran on serum lipids in hypercholesterolemic subjects: relation to apolipoprotein E phenotype.J Am Coll Nutr. 1992 Dec;11(6):651-9. doi: 10.1080/07315724.1992.10718264. J Am Coll Nutr. 1992. PMID: 1334101 Clinical Trial.
-
Oat-bran cereal lowers serum total and LDL cholesterol in hypercholesterolemic men.Am J Clin Nutr. 1990 Sep;52(3):495-9. doi: 10.1093/ajcn/52.3.495. Am J Clin Nutr. 1990. PMID: 2168123 Clinical Trial.
-
The role of fiber in the treatment of hypercholesterolemia in children and adolescents.Pediatrics. 1995 Nov;96(5 Pt 2):1005-9. Pediatrics. 1995. PMID: 7494671 Review.
-
Dietary fiber, lipids and atherosclerosis.Am J Cardiol. 1987 Oct 30;60(12):17G-22G. doi: 10.1016/0002-9149(87)90587-x. Am J Cardiol. 1987. PMID: 2823590 Review.
Cited by
-
Whole grain intake and cardiovascular disease: a review.Curr Atheroscler Rep. 2004 Nov;6(6):415-23. doi: 10.1007/s11883-004-0081-y. Curr Atheroscler Rep. 2004. PMID: 15485586 Review.
-
Beta-glucans in the treatment of diabetes and associated cardiovascular risks.Vasc Health Risk Manag. 2008;4(6):1265-72. doi: 10.2147/vhrm.s3803. Vasc Health Risk Manag. 2008. PMID: 19337540 Free PMC article. Review.
-
Biomedical issues of dietary fiber beta-glucan.J Korean Med Sci. 2006 Oct;21(5):781-9. doi: 10.3346/jkms.2006.21.5.781. J Korean Med Sci. 2006. PMID: 17043406 Free PMC article. Review.
-
Whey Protein Combined with Low Dietary Fiber Improves Lipid Profile in Subjects with Abdominal Obesity: A Randomized, Controlled Trial.Nutrients. 2019 Sep 4;11(9):2091. doi: 10.3390/nu11092091. Nutrients. 2019. PMID: 31487806 Free PMC article. Clinical Trial.
-
Supplementation of the diet with the functional fiber PolyGlycoplex is well tolerated by healthy subjects in a clinical trial.Nutr J. 2009 Feb 5;8:9. doi: 10.1186/1475-2891-8-9. Nutr J. 2009. PMID: 19196472 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous